Progressive fibroplasia ossificans is a genetic condition with an incidence of just one case in every two million babies worldwide
The clinic for the detection of (FOP) became mandatory in . This measure, which covers both public and private networks, was sanctioned by the president and is already covered by (SUS).
The procedure is crucial to identify malformation of the big toes, one of the first signs of FOP, allowing an early diagnosis of this rare and incurable condition. The decision, approved by the Federal Senate at the end of 2024, highlights the importance of early interventions to improve patients’ quality of life.
Progressive fibroplasia ossificans is an extremely rare genetic disease, with an incidence of just one case in every two million newborns worldwide. Currently, it is estimated that around 4,000 people live with this condition globally. FOP is characterized by the abnormal formation of bones in places where they should not normally exist, which can lead to restricted movement and, in more serious cases, permanent immobility of patients.
Published by Luisa Cardoso
